Literature DB >> 6288185

Regional distribution of cholinergic neurons in human spinal cord transections in the patients with and without motor neuron disease.

Y Nagata, M Okuya, R Watanabe, M Honda.   

Abstract

Regional distribution of enzymic activities in acetylcholine (ACh) metabolism was examined on thinly-sectioned transverse slices of human spinal cords obtained during autopsy of 5 motor neuron disease (MND) and 5 control patients without MND. Choline acetyltransferase (ChAT) activity was highly concentrated in the ventral horn regions (gray and white matters) of cervical, thoracic and lumbar spinal cord of non-MND patients. This enzyme activity was found to be remarkably low in the ventral gray and white matter of MND patients compared with that of the controls. Although the distribution of acetylcholinesterase (AChE) activity was found to be high in both ventral and dorsal gray matter of the spinal cord, little difference was observed between each corresponding region of MND and control patients, except relatively low enzyme activity in the cervical ventral horn region of MND patients. Muscarinic cholinergic receptors, examined as specific [3H]quinuclidinylbenzilate ([3H]QNB) binding, was also highly concentrated in the ventral and dorsal gray matter of the control spinal cord, and was strongly reduced in the ventral horn region of MND patients, indicating a quite similar distribution pattern of ChAT activity. These biochemical changes of cholinergic transmission system may be paralleled to the morphological degeneration of the spinal lower motor neurons in MND patients. Activity of 2',3'-cyclic nucleotide-3'-phosphodiesterase (CNPase), a marker enzyme of central myelin structure, was evenly distributed throughout the whole spinal cord section, without regard to the gray and white matter, of both MND and control patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6288185     DOI: 10.1016/0006-8993(82)90081-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  Amyotrophic lateral sclerosis: glutamate dehydrogenase and transmitter amino acids in the spinal cord.

Authors:  S Malessa; P N Leigh; O Bertel; E Sluga; O Hornykiewicz
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-11       Impact factor: 10.154

2.  Alteration of transglutaminase activity in rat and human spinal cord after neuronal degeneration.

Authors:  K Fujita; M Ando; M Yamauchi; Y Nagata; M Honda
Journal:  Neurochem Res       Date:  1995-10       Impact factor: 3.996

3.  Increases in fragmented glial fibrillary acidic protein levels in the spinal cords of patients with amyotrophic lateral sclerosis.

Authors:  K Fujita; T Kato; M Yamauchi; M Ando; M Honda; Y Nagata
Journal:  Neurochem Res       Date:  1998-02       Impact factor: 3.996

4.  Effects of dorsal root section and occlusion of dorsal spinal artery on the neurotransmitter candidates in rat spinal cord.

Authors:  K Fujita; Y Nagata
Journal:  Neurochem Res       Date:  1989-05       Impact factor: 3.996

5.  Effect of unilateral motor cortex ablation on activity of choline acetyltransferase and levels of amino acid transmitter candidates in the spinal cord of adult monkeys.

Authors:  K Fujita; Y Nagata; K Konno; T Kanno; K Selvakumar
Journal:  Neurochem Res       Date:  1993-07       Impact factor: 3.996

6.  Calpain inhibition protects spinal motoneurons from the excitotoxic effects of AMPA in vivo.

Authors:  Juan Carlos Corona; Ricardo Tapia
Journal:  Neurochem Res       Date:  2008-01-25       Impact factor: 3.996

7.  Vascular Endothelial Growth Factor (VEGF) Prevents the Downregulation of the Cholinergic Phenotype in Axotomized Motoneurons of the Adult Rat.

Authors:  Lourdes Acosta; Sara Morcuende; Silvia Silva-Hucha; Angel M Pastor; Rosa R de la Cruz
Journal:  Front Mol Neurosci       Date:  2018-07-12       Impact factor: 5.639

Review 8.  Neuroprotective Effect of Vascular Endothelial Growth Factor on Motoneurons of the Oculomotor System.

Authors:  Silvia Silva-Hucha; Angel M Pastor; Sara Morcuende
Journal:  Int J Mol Sci       Date:  2021-01-15       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.